Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 624 shares at $625.32 ($391K) on 2021-11-01, disclosed to the SEC on 2021-11-02.
Open-market sale of $391k DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $615.13 | 45 | $28K | 7.1% |
| 2 | $619.32 | 14 | $9K | 2.2% |
| 3 | $622.63 | 13 | $8K | 2.1% |
| 4 | $624.10 | 43 | $27K | 6.9% |
| 5 | $625.32 | 124 | $78K | 19.8% |
| 6 | $625.32 | 124 |
| $78K |
| 19.8% |
| 7 | $626.05 | 7 | $4K | 1.1% |
| 8 | $627.79 | 56 | $35K | 9.0% |
| 9 | $628.41 | 76 | $48K | 12.2% |
| 10 | $629.33 | 42 | $26K | 6.8% |
| 11 | $631.26 | 40 | $25K | 6.5% |
| 12 | $634.01 | 40 | $25K | 6.5% |
| Total | $626.12 avg | 624 | $391K | 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |